Hepatitis B virus infection and primary hepatocellular carcinoma. 1977

E Tabor, and R J Gerety, and C L Vogel, and A C Bayley, and P P Anthony, and C H Chan, and L F Barker

Ninety-three patients with biopsy-proven primary hepatocellular carcinoma (PHC) from Uganda, Zambia, and the United States were examined for serologic evidence of hepatitis B virus (HBV) infection. Patients were tested for hepatitis B surface antigen (HBsAg) and its antibody (anti-HBs), antibody to the hepatitis B core antigen (anti-HBc), hepatitis B e antigen (HBeAg), and its antibody (anti-HBe). Active HBV infection, as indicated by positive tests for HBsAg (with or without anti-HBs) and anti-HBc (without anti-HBs), was present in 62% of PHC patients (58 of 93), in contrast with 10% of African controls (9 of 90), and less than 1% of most United States adult populations reported in the literature. The presence of HBeAg or anti-HBe was rare among PHC patients and controls.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis

Related Publications

E Tabor, and R J Gerety, and C L Vogel, and A C Bayley, and P P Anthony, and C H Chan, and L F Barker
January 1991, Cancer investigation,
E Tabor, and R J Gerety, and C L Vogel, and A C Bayley, and P P Anthony, and C H Chan, and L F Barker
July 1992, Clinical microbiology reviews,
E Tabor, and R J Gerety, and C L Vogel, and A C Bayley, and P P Anthony, and C H Chan, and L F Barker
January 1990, Cancer,
E Tabor, and R J Gerety, and C L Vogel, and A C Bayley, and P P Anthony, and C H Chan, and L F Barker
January 1983, Journal of medical virology,
E Tabor, and R J Gerety, and C L Vogel, and A C Bayley, and P P Anthony, and C H Chan, and L F Barker
January 1981, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale,
E Tabor, and R J Gerety, and C L Vogel, and A C Bayley, and P P Anthony, and C H Chan, and L F Barker
June 1982, Current problems in cancer,
E Tabor, and R J Gerety, and C L Vogel, and A C Bayley, and P P Anthony, and C H Chan, and L F Barker
April 1983, Gastroenterology,
E Tabor, and R J Gerety, and C L Vogel, and A C Bayley, and P P Anthony, and C H Chan, and L F Barker
January 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene,
E Tabor, and R J Gerety, and C L Vogel, and A C Bayley, and P P Anthony, and C H Chan, and L F Barker
January 1988, Cancer investigation,
E Tabor, and R J Gerety, and C L Vogel, and A C Bayley, and P P Anthony, and C H Chan, and L F Barker
August 2010, Pathologie-biologie,
Copied contents to your clipboard!